Dialysis patients are at risk for infection by a variety of blood-borne agents trasmitted within dialysis units.
The development of the hepatitis C virus (HCV) screening test prompted many studies on the prevalence of anti-HCV among dialysis patients.
The authors have evaluated the prevalence of anti-HCV in 405 hemodialysis patients both by Elisa screening and 4-RIBA test system with a follow-up of two years.
The study showed a difference in the incidence of antibodies to HCV by year.
In 1990, 15.2% were positive with an increase to 20.8% in 1991.
Mots-clés Pascal : Hépatite virale C, Virose, Infection, Sérologie, Epidémiologie, Homme, Prévalence, Dépistage, Hémodialyse, Epuration extrarénale, Foie pathologie, Appareil digestif pathologie, Italie, Europe
Mots-clés Pascal anglais : Viral hepatitis C, Viral disease, Infection, Serology, Epidemiology, Human, Prevalence, Medical screening, Hemodialysis, Extrarenal dialysis, Hepatic disease, Digestive diseases, Italy, Europe
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0412251
Code Inist : 002B05C02G. Création : 199406.